Evidence map›Paper›PMID 33449444›Full record

ArticleFEBS open bio2021

IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.

Zhi-Nan Xia, Xing-Yuan Wang, Li-Cheng Cai, Wen-Gang Jian, Cheng Zhang

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zhi-Nan XiaDepartment of Urology, The First Affiliated Hospital of Harbin Medical University, China.ORCID 0000-0003-0423-4405
Xing-Yuan WangDepartment of Urology, The First Affiliated Hospital of Harbin Medical University, China.ORCID 0000-0002-5785-2357
Li-Cheng CaiDepartment of Urology, The First Affiliated Hospital of Harbin Medical University, China.ORCID 0000-0003-3994-9339
Wen-Gang JianDepartment of Urology, The First Affiliated Hospital of Harbin Medical University, China.ORCID 0000-0001-6730-260X
Cheng ZhangDepartment of Urology, The First Affiliated Hospital of Harbin Medical University, China.ORCID 0000-0001-6639-3749
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinomas (RCCs) account for about 90% of renal tumors, and their major histological subtype is ccRCC (clear cell RCC). Increasing evidence has indicated that the tumor microenvironment plays a significant role in the occurrence and development of ccRCC. In this study, we used ESTIMATE and CIBERSORT computational methods to calculate the proportion of immune and stromal components and the rate of TICs (tumor-infiltrating immune cells) in 539 ccRCC samples from The Cancer Genome Atlas database. By examining the intersection of the differentially expressed genes obtained by the protein-protein interaction network and Cox regression analysis, we identified only one overlapping gene: IGLL5 (immunoglobulin lambda-like polypeptide 5). We report that IGLL5 expression is correlated with TICs. Furthermore, our immunoinfiltration analyses revealed that three types of TIC are positively correlated with IGLL5 expression. IGLL5 may have potential as a prognostic biomarker of ccRCC.

Indexed as

Biomarkers, TumorCarcinoma, Renal CellComputational BiologyFemaleHumansImmunoglobulin Light Chains, SurrogateKidney NeoplasmsLymphocytes, Tumor-InfiltratingMaleNeoplasm StagingPrognosisProtein Interaction MapsSurvival AnalysisTumor MicroenvironmentBiomarkers, TumorImmunoglobulin Light Chains, SurrogateCIBERSORTclear cell renal cell carcinomaESTIMATEIGLL5tumor-infiltrating immune cellstumor microenvironment

Identifiers

PMID33449444
PMCPMC7931224
OpenAlexW3119687579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.